Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-07-21 Purchase | 2020-07-21 8:03 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director | 3,000 | $19 | $57,000 | 3,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-22 Option Award | 2023-06-23 5:31 pm | N/A 2033-06-21 | MAXCYTE INC. | MXCT | Hemrajani Rekha Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-06-20 Option Award | 2023-06-22 4:43 pm | N/A 2033-06-19 | ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director | 20,200 | $0 | 20,200 (Direct) | View |
| 2023-03-20 Option Award | 2023-03-21 4:45 pm | N/A 2033-03-19 | MAXCYTE INC. | MXCT | Hemrajani Rekha Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-29 Option Award | 2022-07-08 4:03 pm | N/A 2032-06-28 | MAXCYTE INC. | MXCT | Hemrajani Rekha Director | 26,900 | $0 | 26,900 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 8:23 pm | N/A 2032-06-14 | ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director | 12,004 | $0 | 12,004 (Direct) | View |
| 2021-08-09 Option Award | 2021-08-11 5:15 pm | N/A 2031-08-09 | MAXCYTE INC. | MXCT | Hemrajani Rekha Director | 10,000 | $0 | 10,000 (Direct) | View |
Ownership | 2021-07-29 6:37 pm | N/A 2031-06-14 | MAXCYTE INC. | MXCT | Hemrajani Rekha Director | 0 | $0 | 80,700 (Direct) | View |
| 2021-06-11 Option Award | 2021-06-15 6:50 pm | N/A 2031-06-10 | ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director | 12,004 | $0 | 12,004 (Direct) | View |
Ownership | 2020-11-18 8:10 pm | N/A N/A | Jiya Acquisition Corp. | JYAC | Hemrajani Rekha Chief Executive Officer | 0 | $0 | 200,000 (Direct) | View |
Ownership | 2020-07-16 6:37 pm | N/A 2030-04-29 | ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director | 0 | $0 | 87,378 (Direct) | View |
| 2020-06-23 Option Award | 2020-06-25 5:45 pm | N/A 2030-06-22 | Adverum Biotechnologies Inc. | ADVM | Hemrajani Rekha Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-04-08 Disposition | 2020-04-09 4:10 pm | N/A N/A | Aravive Inc. | ARAV | Hemrajani Rekha See Remarks | 42,750 | $0 | 14,250 (Direct) | View |
| 2020-01-09 Option Award | 2020-01-09 7:20 pm | 2021-01-09 2030-01-08 | Aravive Inc. | ARAV | Hemrajani Rekha President and CEO | 200,000 | $0 | 200,000 (Direct) | View |
| 2019-08-15 Option Award | 2019-08-16 4:15 pm | N/A 2029-07-30 | Adverum Biotechnologies Inc. | ADVM | Hemrajani Rekha Director | 33,750 | $0 | 45,000 (Direct) | View |
| 2019-07-31 Option Award | 2019-08-02 4:21 pm | N/A 2029-07-30 | Adverum Biotechnologies Inc. | ADVM | Hemrajani Rekha Director | 11,250 | $0 | 11,250 (Direct) | View |
| 2019-05-01 Option Award | 2019-05-03 4:38 pm | N/A 2029-04-30 | Adverum Biotechnologies Inc. | ADVM | Hemrajani Rekha Director | 70,000 | $0 | 70,000 (Direct) | View |
Ownership | 2019-05-03 4:32 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Hemrajani Rekha Director | 0 | $0 | 0 (Direct) | View |